OSPOLOT 20 mg/ml susp 20 mg 250 ml

7680698280019 CH-69828 N03AX03 01.07.1.

Active substances:

No images available

Details

Product number
6982801
CPT
-
Packaging group
250
Unit
ml
Composition
sultiamum 20 mg, E 219 2.3 mg, propylis parahydroxybenzoas natricus 0.6 mg, sucralosum, natrii docusas, xanthani gummi, natrii dihydrogenophosphas dihydricus, dikalii phosphas anhydricus, aromatica (Erdbeer), aromatica (Geschmacksmodulator) cum E 220 et fructosum et glucosum et saccharum, aromatica (Aroma zur Geschmacksmaskierung), acidum phosphoricum concentratum, aqua purificata ad solutionem pro 1 ml corresp. natrium 0.667 mg.

Articles (1)

Ospolot 20 mg/ml, Suspension zum Einnehmen
suspension
250
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/03/2026
Patient information leaflet
Français
18/03/2026
Patient information leaflet
Italien
18/03/2026

Detailed composition

Substance Quantity Type Category
sultiamum
20.0 MG Substance Wirkstoff (Principe actif)
E 219
2.3 MG Substance HBESI
propylis parahydroxybenzoas natricus
0.6 MG Substance HBESI
sucralosum
- Substance HNIDK
natrii docusas
- Substance HNIDK
xanthani gummi
- Substance HNIDK
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
dikalii phosphas anhydricus
- Substance HNIDK
aromatica
- Substance AROMA
aromatica
- Substance AROMA
E 220
- Substance HBESI
fructosum
- Substance HBESI
glucosum
- Substance HBESI
saccharum
- Substance HBESI
aromatica
- Substance AROMA
acidum phosphoricum concentratum
- Substance HNIDK
aqua purificata
- Substance HNIDK
natrium
0.667 MG Substance HBESI

Reimbursement information

Public price
CHF 121.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2026

Authorization holder

Desitin Pharma GmbH

4410 Liestal

Authorization information

Swissmedic authorization number
69828
Drug name
Ospolot, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
N03AX03
Authorization status
Z
Dispensation category
B
First authorization
05/08/2025
Authorization expiration date
04/08/2030
IT number
01.07.1.
Domain
Human medicine
Field of application
Antiepileptikum

Packaging details

Description (FR)
OSPOLOT 20 mg/ml susp 20 mg 250 ml
Description (DE)
OSPOLOT 20 mg/ml Susp 20 mg 250 ml
Market launch
01/02/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data